Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CDER’s Woodcock Retiring? Rumors Never Go On Furlough

Executive Summary

On day 10 of the federal government shutdown, a Reuters story sparks concern inside and outside the agency that FDA’s drugs center director could soon retire without an obvious successor waiting in the wings; Woodcock fires back with a memo assuring CDER staff she has no plans to leave.

You may also be interested in...



Woodcock's Legacy: CDER Organizational Improvements

In interview with the Pink Sheet, Center for Drug Evaluation and Research director discusses her 30-year career, retirement speculation, and upcoming projects.

CBER Director Midthun Retiring; Legacy Includes Biosimilar Principles, Avastin Withdrawal

While CBER is often perceived to be as much focused on research as it is on application review, Midthun was central to many key policy debates.

Shutdown Week Two: Could Sponsors Find A More Focused FDA?

User-fee supported employees continue to work on pending reviews, and the lack of distractions from other tasks may help sponsors as the shutdown continues.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS055676

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel